RecruitingPhase 3NCT07067463
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Sponsor: Zenas BioPharma (USA), LLC
San Antonio, TX · Sherman, TX · +17 more sites
Clinical trials in Sherman, TX
11 recruiting studies have a site in or near Sherman, TX, Texas.
Top conditions here
- Heart Failure (3)
- Hypertension (2)
- Multiple Sclerosis (2)
- Parkinson's Disease (1)
- COPD (1)
- Type 2 Diabetes (1)
- Migraine (1)
- Obesity (1)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 11 of 11 studies
RecruitingPhase 3NCT07181109
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Sponsor: Alnylam Pharmaceuticals
Allen, TX · Amarillo, TX · +270 more sites
RecruitingPhase 3NCT05156398
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Sponsor: Pfizer
Dallas, TX · Frisco, TX · Houston, TX · +53 more sites
RecruitingPhase 3NCT07064473
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Sponsor: Boehringer Ingelheim
Austin, TX · Brownsville, TX · +205 more sites
RecruitingPhase not listedNCT02071134
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Sponsor: Boston Scientific Corporation
Houston, TX · San Antonio, TX · Sherman, TX · +26 more sites
RecruitingPhase 3NCT06307652
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Sponsor: AstraZeneca
Allen, TX · Amarillo, TX · +163 more sites
RecruitingPhase 3NCT07299019
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Sponsor: Zenas BioPharma (USA), LLC
San Antonio, TX · Sherman, TX · +24 more sites
RecruitingPhase 2NCT06343298
To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension
Sponsor: E-Star BioTech, LLC
Coppell, TX · Dallas, TX · Denton, TX · +20 more sites
RecruitingPhase 3NCT07037459
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Sponsor: Amgen
Amarillo, TX · Austin, TX · Conroe, TX · +118 more sites
RecruitingPhase 2 / Phase 3NCT07363694
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Sponsor: Pfizer
Boerne, TX · Carrollton, TX · Cypress, TX · +58 more sites
RecruitingPhase 3NCT07567001
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Sponsor: Novo Nordisk A/S
Amarillo, TX · Austin, TX · Conroe, TX · +203 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.